2022
DOI: 10.1016/j.healun.2022.01.1304
|View full text |Cite
|
Sign up to set email alerts
|

Obesity in Pediatric Transplant and the Use of Liraglutide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The efficacy and tolerability reports from real-world studies thus far are promising 9. GLP-1 analogues are widely used in clinical practice for patients with obesity both with and without diabetes and use for these reasons in the pretransplant period has already been described in one case of a paediatric heart transplantation,10 and for weight optimisation prior to kidney and liver transplantation in adults 11 12. GLP-1 analogue use for weight management in preparation for lung transplantation has not previously been described in the literature.…”
Section: Discussionmentioning
confidence: 99%
“…The efficacy and tolerability reports from real-world studies thus far are promising 9. GLP-1 analogues are widely used in clinical practice for patients with obesity both with and without diabetes and use for these reasons in the pretransplant period has already been described in one case of a paediatric heart transplantation,10 and for weight optimisation prior to kidney and liver transplantation in adults 11 12. GLP-1 analogue use for weight management in preparation for lung transplantation has not previously been described in the literature.…”
Section: Discussionmentioning
confidence: 99%